(Q42740575)

6 November 2017

Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis (English)

1 reference

cerebrotendinous xanthomatosis

6 November 2017

1 reference

Lewis B

1

1 reference

6 November 2017

Mitchell WD

2

1 reference

6 November 2017

Marenah CB

3

1 reference

6 November 2017

Cortese C

4

1 reference

6 November 2017

Reynolds EH

5

1 reference

6 November 2017

Shakir R

6

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 July 1983

1 reference

6 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

The BMJ

1 reference

6 November 2017

287

1 reference

6 November 2017

6384

1 reference

6 November 2017

21-22

1 reference

Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1548166

PubMed Central

reference URL

Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1548166

PubMed Central

reference URL

Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1548166

PubMed Central

reference URL

10.1136/BMJ.287.6384.21-A

16 August 2018

Identifiers

DOI

0 references

1 reference

6 November 2017

PubMed publication ID

6407679

1 reference